Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 2
1973 2
1974 1
1975 6
1976 3
1978 2
1979 1
1981 2
1982 2
1984 1
1986 2
1987 1
1988 2
1991 3
1992 2
1993 1
1995 3
1998 3
2000 1
2003 2
2006 1
2008 1
2009 2
2010 1
2011 2
2013 2
2016 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Interferons for viral hepatitis.
Terrault N, Feinman SV. Terrault N, et al. Among authors: feinman sv. Transfus Med Rev. 1995 Jan;9(1):29-52. doi: 10.1016/s0887-7963(05)80029-x. Transfus Med Rev. 1995. PMID: 7536498 Review. No abstract available.
Hepatitis in undertakers.
Berris B, Feinman SV, Richardson B, Wrobel DW, Sinclair JC. Berris B, et al. Among authors: feinman sv. JAMA. 1978 Jul 14;240(2):138-9. JAMA. 1978. PMID: 660831
Boceprevir for untreated chronic HCV genotype 1 infection.
Poordad F, McCone J Jr, Bacon BR, Bruno S, Manns MP, Sulkowski MS, Jacobson IM, Reddy KR, Goodman ZD, Boparai N, DiNubile MJ, Sniukiene V, Brass CA, Albrecht JK, Bronowicki JP; SPRINT-2 Investigators. Poordad F, et al. N Engl J Med. 2011 Mar 31;364(13):1195-206. doi: 10.1056/NEJMoa1010494. N Engl J Med. 2011. PMID: 21449783 Free PMC article. Clinical Trial.
The incidence of post-transfusion hepatitis.
Blajchman MA, Feinman SV, Bull SB. Blajchman MA, et al. Among authors: feinman sv. N Engl J Med. 1993 Apr 29;328(17):1280-1. doi: 10.1056/NEJM199304293281716. N Engl J Med. 1993. PMID: 8464452 No abstract available.
Liver disease--etiological aspects.
Feinman SV. Feinman SV. Appl Ther. 1968 Apr;10(4):249-53. Appl Ther. 1968. PMID: 5655420 No abstract available.
Liver disease--clinical diagnosis.
Feinman SV. Feinman SV. Appl Ther. 1968 Apr;10(4):254-6. Appl Ther. 1968. PMID: 5655421 No abstract available.
Posttransfusion hepatitis in Toronto, Canada.
Feinman SV, Berris B, Bojarski S. Feinman SV, et al. Gastroenterology. 1988 Aug;95(2):464-9. doi: 10.1016/0016-5085(88)90505-7. Gastroenterology. 1988. PMID: 3134269
Boceprevir for previously treated chronic HCV genotype 1 infection.
Bacon BR, Gordon SC, Lawitz E, Marcellin P, Vierling JM, Zeuzem S, Poordad F, Goodman ZD, Sings HL, Boparai N, Burroughs M, Brass CA, Albrecht JK, Esteban R; HCV RESPOND-2 Investigators. Bacon BR, et al. N Engl J Med. 2011 Mar 31;364(13):1207-17. doi: 10.1056/NEJMoa1009482. N Engl J Med. 2011. PMID: 21449784 Free PMC article. Clinical Trial.
Peginterferon alfa-2a in patients with chronic hepatitis C.
Zeuzem S, Feinman SV, Rasenack J, Heathcote EJ, Lai MY, Gane E, O'Grady J, Reichen J, Diago M, Lin A, Hoffman J, Brunda MJ. Zeuzem S, et al. Among authors: feinman sv. N Engl J Med. 2000 Dec 7;343(23):1666-72. doi: 10.1056/NEJM200012073432301. N Engl J Med. 2000. PMID: 11106715 Free article. Clinical Trial.
Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials.
Jensen DM, Asselah T, Dieterich D, Foster GR, Sulkowski MS, Zeuzem S, Mantry P, Yoshida EM, Moreno C, Ouzan D, Wright M, Morano LE, Buynak R, Bourlière M, Hassanein T, Nishiguchi S, Kao JH, Omata M, Paik SW, Wong DK, Tam E, Kaita K, Feinman SV, Stern JO, Scherer J, Quinson AM, Voss F, Gallivan JP, Böcher WO, Ferenci P. Jensen DM, et al. Among authors: feinman sv. Ann Hepatol. 2016 May-Jun;15(3):333-49. doi: 10.5604/16652681.1198803. Ann Hepatol. 2016. PMID: 27049487 Free article.
53 results